Margarida L Ferreira Martins

4PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 28, 2023
Enhancement of the Oral Availability of Cabazitaxel Using the Cytochrome P450 3A (CYP3A) Inhibitor Ritonavir in Mice.

Nancy H C Loos, Margarida L F Martins, Daniëlle de Jong

|Nov 03, 2021
P-Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib.

Margarida L F Martins, Nancy H C Loos, Sümeyra Mucuk

|Mar 31, 2021
ABCB1 and ABCG2 Restrict Brain and Testis Accumulation and, Alongside CYP3A, Limit Oral Availability of the Novel TRK Inhibitor Selitrectinib.

Wenlong Li, Rolf W Sparidans, Margarida L F Martins

Pageof 1